We are live on ! Find out more
CCG

Cypress Capital Group Portfolio holdings

AUM $889M
1-Year Est. Return 27.23%
This Fund
S&P 500
This Quarter Est. Return
-4.95%
1 Year Est. Return
+27.23%
3 Year Est. Return
+83.89%
5 Year Est. Return
+113.23%
10 Year Est. Return
+324.61%
AUM
$600M
AUM Growth
-$56.5M
Cap. Flow
-$20.9M
Cap. Flow %
-3.49%
Top 10 Hldgs %
27.39%
Holding
291
New
12
Increased
95
Reduced
152
Closed
16

Top Buys

Rank Stock Value
1
PSX icon
Phillips 66
PSX
+$2.66M
2
NEE icon
NextEra Energy
NEE
+$1.29M
3
DUK icon
Duke Energy
DUK
+$1.21M
4
CVX icon
Chevron
CVX
+$1.14M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$999K

Sector Composition

Rank Sector Weight
1 Healthcare 20.07%
2 Technology 16.61%
3 Financials 10.31%
4 Consumer Discretionary 9.02%
5 Consumer Staples 7.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYB icon
201
LyondellBasell Industries
LYB
$19.5B
$409K 0.07%
5,435
-2,601
-32% -$220K
BKNG icon
202
Booking.com
BKNG
$156B
$406K 0.07%
+6,175
New +$464K
NSC icon
203
Norfolk Southern
NSC
$75.4B
$405K 0.07%
1,934
-1,164
-38% -$280K
VRSN icon
204
VeriSign
VRSN
$26.3B
$401K 0.07%
2,308
-21
-0.9% -$3.88K
IWO icon
205
iShares Russell 2000 Growth ETF
IWO
$14.1B
$400K 0.07%
1,932
+85
+5% +$19.1K
CCK icon
206
Crown Holdings
CCK
$13B
$394K 0.07%
4,859
PLD icon
207
Prologis
PLD
$136B
$389K 0.06%
3,827
-157
-4% -$19.5K
LNT icon
208
Alliant Energy
LNT
$18.6B
$387K 0.06%
7,305
-80
-1% -$4.83K
BA icon
209
Boeing
BA
$169B
$384K 0.06%
3,170
+13
+0.4% +$1.99K
VRTX icon
210
Vertex Pharmaceuticals
VRTX
$123B
$377K 0.06%
1,301
+510
+64% +$147K
TSN icon
211
Tyson Foods
TSN
$21.5B
$368K 0.06%
5,585
-2,641
-32% -$209K
IWS icon
212
iShares Russell Mid-Cap Value ETF
IWS
$15.7B
$357K 0.06%
3,717
+119
+3% +$12.7K
TD icon
213
Toronto Dominion Bank
TD
$193B
$356K 0.06%
5,809
+39
+0.7% +$2.52K
BIV icon
214
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
$354K 0.06%
+4,817
New +$373K
DPZ icon
215
Domino's
DPZ
$11.9B
$352K 0.06%
1,134
-2
-0.2% -$759
MAS icon
216
Masco
MAS
$14.6B
$352K 0.06%
7,532
-4,192
-36% -$218K
VB icon
217
Vanguard Small-Cap ETF
VB
$78.9B
$344K 0.06%
2,013
-464
-19% -$87.6K
IDXX icon
218
Idexx Laboratories
IDXX
$44.9B
$340K 0.06%
1,044
-4
-0.4% -$1.47K
EQIX icon
219
Equinix
EQIX
$99.4B
$339K 0.06%
596
-26
-4% -$17K
NVS icon
220
Novartis
NVS
$302B
$333K 0.06%
4,381
-55
-1% -$4.56K
IWP icon
221
iShares Russell Mid-Cap Growth ETF
IWP
$19.4B
$330K 0.06%
4,205
+175
+4% +$15.1K
SO icon
222
Southern Company
SO
$108B
$327K 0.05%
4,812
-453
-9% -$34.3K
FAST icon
223
Fastenal
FAST
$54.8B
$326K 0.05%
14,150
-2,472
-15% -$62.3K
EXPE icon
224
Expedia Group
EXPE
$36.5B
$324K 0.05%
3,458
-38
-1% -$3.88K
USMV icon
225
iShares MSCI USA Min Vol Factor ETF
USMV
$23.6B
$322K 0.05%
4,872
-30
-0.6% -$2.16K

Similar funds

Cypress Capital Group's Q3 2022 Portfolio in Review

As of Q3 2022, Cypress Capital Group held 291 positions worth $600M, down 8.6% from $656M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Cypress Capital Group withdrew a net $20.9M in Q3 2022, closing 16 positions and reducing 152 holdings. Its most notable exit was iShares China Large-Cap ETF, an estimated $747K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.

Against the trend, Cypress Capital Group opened a new position in Regeneron Pharmaceuticals worth $1.09M.

  • Cypress Capital Group's largest Q3 2022 buy was Regeneron Pharmaceuticals: 1,587 shares worth $1.09M.
  • Cypress Capital Group added most to Phillips 66 in Q3 2022, an estimated $2.66M increase.
  • Cypress Capital Group's biggest Q3 2022 reduction was First Trust Managed Municipal ETF, cutting an estimated $3.03M.
  • Cypress Capital Group fully exited iShares China Large-Cap ETF in Q3 2022, selling an estimated $747K.
  • Cypress Capital Group's ten largest holdings make up 27% of its $600M portfolio in Q3 2022.
  • Cypress Capital Group opened 12 new positions and closed 16 in Q3 2022.
  • Cypress Capital Group's portfolio value fell 8.6% quarter-over-quarter to $600M.

Based on Cypress Capital Group's 13F filing for Q3 2022, filed 4 Nov 2022.